Factors influencing clinical outcomes of Histoacryl® glue injection-treated gastric variceal hemorrhage

Table 5 Correlation analysis of factors associated with mortality at final follow-up

Factors	Mortality
			Univariate			Multivariate
	Yes (n = 19)	No (n = 71)	P value	95%CI	OR	P value	95%CI	OR
Age, yr	56.4 ± 3.34	55.8 ± 1.65	0.95
Decompensated liver diseases
Yes	18	53	0.10
MELD score > 12	8	14	0.06
Ascites	13	28	0.041	1.05-9.12	3.09	-	-	-
Encephalopathy	6	11	0.29
Total bilirubin, mg/dL	8.50 ± 6.71	2.73 ± 2.93	< 0.011			< 0.011	3.28-85.09	16.7
Concurrent HCC
Yes	10	19	0.031	1.05-8.47	2.98	-	-	-
Transfusion volume
PRC, unit	5.68 ± 3.32	2.87 ± 2.28	< 0.011			-	-	-
FFP, mL	1934.00 ± 1850.78	611.76 ± 724.89	< 0.011			0.031	1.000-1.002	1.001
Type of gastric varix
GOV	14	56	0.54
IGV	5	14
Mean GV size, cm	1.97 ± 0.74	2.16 ± 0.89	0.38
Mean aliquot number/procedure	4.13 ± 1.99	2.76 ± 1.57	< 0.011			-	-	-
Early re-bleeding
Yes	7	2	< 0.011	3.72-108.3	20.12	-	-	-
Late re-bleeding
Yes	8	11	< 0.011	3.35-34.91	10.32	< 0.011	2.15-56.35	10.99

¹Statistically significant difference. HCC: Hepatocellular carcinoma; MELD: Model of end-stage liver disease; PRC: Packed red cell; FFP: Fresh frozen plasma; OR: Odds ratio.